Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ResMed Inc. (RMD) vs Energy Fuels Inc Ordinary Shares (Canada) (UUUU) Price & Performance

ResMed Inc.Trade
Energy Fuels Inc Ordinary Shares (Canada)Trade

Price performance (Past 24H)

Key statistics

ResMed Inc. vs Energy Fuels Inc Ordinary Shares (Canada) — how do they compare? ResMed Inc. trades at $237 (market cap $32.99B), while Energy Fuels Inc Ordinary Shares (Canada) trades at $8.3 (market cap $2.45B). The key difference: ResMed Inc. is far larger — about 13.5× Energy Fuels Inc Ordinary Shares (Canada)'s market cap, and ResMed Inc. pays a 1.13% dividend while Energy Fuels Inc Ordinary Shares (Canada) pays none. Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Energy Fuels Inc Ordinary Shares (Canada) for 0 Days on average.

RMDUUUU
Market Cap
$32.99B$2.45B
Volume
1,023,3817,967,898
Sector
HealthEnergy
52-Week High
$275.96$27.72
52-Week Low
$182.82$8.34
Typical Hold Time
51 Days0 Days
Enterprise Value
$32.35B$2.19B
Dividend Yield
1.13%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ResMed Inc.

ResMed (RMD) trades at $235.29, up 0.29% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 27.2% net margins and consistent earnings beats in recent quarters. Recent news highlights include upcoming Q1 2027 earnings and management presentations at healthcare conferences, while analyst consensus remains positive with a $243.56 price target.

RMD presents a favorable investment case with strong profitability metrics and positive earnings momentum, though elevated valuation ratios and ongoing legal investigations warrant caution. The stock's technical strength supports near-term upside potential toward resistance levels, while fundamental growth drivers in sleep therapy demand provide long-term support.

Energy Fuels Inc Ordinary Shares (Canada)

Energy Fuels (UUUU) trades at $9.27, down 4.04% amid negative sentiment following a securities fraud investigation announcement. The stock shows weak technical positioning near recent lows with neutral indicators. Fundamentally, the company continues to report significant losses with a -77.3% net income margin despite revenue growth projections, while heavy investment in uranium and rare earth expansion creates substantial cash burn.

While analyst consensus remains bullish with a $21.06 price target representing 127% upside, execution risks are elevated. The securities investigation, persistent losses, and massive capital requirements for growth projects create substantial headwinds. Success depends on the company's ability to fund expansion and achieve profitability in the competitive critical minerals sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RMD

No sentiment data available yet.

UUUU
69% Buy31% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →

About Energy Fuels Inc Ordinary Shares (Canada)

Energy Fuels Inc. is a US producer of uranium, vanadium, and rare earth elements. It operates the White Mesa Mill in Utah, the only fully licensed and operating conventional uranium processing facility in the country.

Read more on UUUU →